Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05958095Not ApplicableUnknown

Curio Digital Therapy for the Treatment of Post-partum Depression

Role: lead

NCT05032404Not ApplicableCompleted

Blue Note Therapeutics Product BNT 103 Usability and User Engagement

Role: collaborator

NCT03168685Not ApplicableUnknown

Hemophilia Mobile App Usability Pilot

Role: lead

NCT03222284Not ApplicableUnknown

The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powered by Glooko App

Role: lead

NCT02896660Not ApplicableUnknown

Probuphine Innovations for Clinical Effectiveness (PRINCE)

Role: lead

All 5 trials loaded